TMCnet News
PharmaScroll Unveils Groundbreaking Expansion of Key Opinion Leader Database: Empowering Pharmaceutical Industry with Cutting-Edge Market InsightsHYDERABAD, India, Jan. 29, 2024 /PRNewswire/ -- PharmaScroll, a renowned market research and business analytics company, proudly announces expansion for its Key Opinion Leader (KOL) Database, TreasureTell. This groundbreaking enhancement is set to revolutionize the way pharmaceutical companies identify and engage with key opinion leaders (KOLs), enabling them to make informed decisions and drive innovation in the industry. PharmaScroll has earned a sterling reputation as a trusted partner for the pharmaceutical sector, providing unparalleled market intelligence and strategic guidance. With the expansion of the KOL Database, the company is taking a giant leap forward in empowering clients to harness the power of influential thought leaders and gain a competitive edge in the global market. Key Features of the Expanded KOL Database:
To celebrate the product expansion, PharmaScroll is offering exclusive trial access to interested parties. To request a personalized demo, simply contact: [email protected] or +91-9618379037 About PharmaScroll: PharmaScroll is a leading market research and business analytics company dedicated to empowering the pharmaceutical industry with actionable insights and strategic support. With a team of industry experts and innovative technology, PharmaScroll delivers comprehensive market intelligence and competitive analysis, enabling clients to make informed decisions and achieve success in the global marketplace. For media inquiries or additional information about the expanded Pharma KOL Database, please visit our website: PharmaScroll.
Logo: https://mma.prnewswire.com/media/2328621/PharmaScroll_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/pharmascroll-unveils-groundbreaking-expansion-of-key-opinion-leader-database-empowering-pharmaceutical-industry-with-cutting-edge-market-insights-302046618.html SOURCE PharmaScroll |